Hybrid Biosystems and Myotec merge
Seed-stage investor The Mercia Fund has merged portfolio companies Hybrid Biosystems and Myotec to form PsiOxus Therapeutics in a deal that has attracted £3.6 million in funding.
News
Seed-stage investor The Mercia Fund has merged portfolio companies Hybrid Biosystems and Myotec to form PsiOxus Therapeutics in a deal that has attracted £3.6 million in funding.
News
News